Published in Cancer Epidemiol Biomarkers Prev on November 01, 1997
Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice. Cancer Prev Res (Phila) (2010) 1.91
Supplement use and risk of cutaneous squamous cell carcinoma. J Am Acad Dermatol (2011) 1.52
A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer. Cancer Prev Res (Phila) (2010) 1.21
Tumor-suppressive activity of retinoic acid receptor-beta in cancer. Cancer Lett (2006) 1.13
Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer. J Clin Aesthet Dermatol (2010) 0.96
Nonsurgical innovations in the treatment of nonmelanoma skin cancer. J Clin Aesthet Dermatol (2010) 0.89
Reexamination of a meta-analysis of the effect of antioxidant supplementation on mortality and health in randomized trials. Nutrients (2010) 0.84
Withania somnifera: From prevention to treatment of cancer. Mol Nutr Food Res (2016) 0.80
Chemoprevention of human actinic keratoses by topical DL-alpha-tocopherol. Cancer Prev Res (Phila) (2009) 0.78
New agents for prevention of ultraviolet-induced nonmelanoma skin cancer. Semin Cutan Med Surg (2011) 0.76
The protective effect of amifostine on ultraviolet B-exposed xeroderma pigmentosum mice. Ecancermedicalscience (2010) 0.75
Headway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivatives. AAPS J (2014) 0.75
Familiar drugs may prevent cancer. Postgrad Med J (2001) 0.75
Dietary Supplements and Risk of Cause-Specific Death, Cardiovascular Disease, and Cancer: A Systematic Review and Meta-Analysis of Primary Prevention Trials. Adv Nutr (2017) 0.75
Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (1997) 7.95
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol (2000) 6.06
Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med (1978) 5.78
Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4. Experientia (1989) 2.90
Micropuncture studies of the electrochemical aspects of fluid and electrolyte transport in individual seminiferous tubules, the epididymis and the vas deferens in rats. J Physiol (1971) 2.44
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene (2012) 2.41
Diffusion tensor imaging of the brain: review of clinical applications. Neuroradiology (2004) 2.37
Direct cloning of human ovarian carcinoma cells in agar. Cancer Res (1978) 2.24
Colon cancer reduction. Questions about implementation of proven techniques. Arch Intern Med (1997) 2.12
Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst (1994) 2.05
Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am J Respir Cell Mol Biol (1999) 2.04
Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res (1997) 1.96
Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res (1995) 1.94
Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology (2001) 1.88
Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev (2001) 1.87
Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. Cancer Res (1986) 1.75
Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol Cell Biol (1997) 1.68
Tretinoin emollient cream: a new therapy for photodamaged skin. J Am Acad Dermatol (1992) 1.59
Slowly fading super-luminous supernovae that are not pair-instability explosions. Nature (2013) 1.52
Cyclosporine as maintenance therapy in patients with severe psoriasis. J Am Acad Dermatol (1997) 1.51
Characterization of the activating region of Escherichia coli catabolite gene activator protein (CAP). I. Saturation and alanine-scanning mutagenesis. J Mol Biol (1994) 1.50
Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs (1996) 1.49
Characterization of a calcium-activated chloride channel as a shared target of Th2 cytokine pathways and its potential involvement in asthma. Am J Respir Cell Mol Biol (2001) 1.47
Analogues of amonafide and azonafide with novel ring systems. J Med Chem (2000) 1.47
Visits by adults to family physicians for the common cold. J Fam Pract (1998) 1.46
Effect of beta-carotene on lymphocyte subpopulations in elderly humans: evidence for a dose-response relationship. Am J Clin Nutr (1991) 1.45
beta-Carotene treatment of cervical intraepithelial neoplasia: a phase II study. Cancer Epidemiol Biomarkers Prev (1996) 1.43
Reliability and validity of a self-administered food frequency questionnaire in a chemoprevention trial of adenoma recurrence. Cancer Epidemiol Biomarkers Prev (1999) 1.42
Design of antineoplastic agents on the basis of the "2-phenylnaphthalene-type" structural pattern. 2. Synthesis and biological activity studies of benzo]b]naphtho[2,3-d]furan-6,11-dione derivatives. J Med Chem (1993) 1.41
Localized pemphigoid simulating dyshidrosiform dermatitis. Arch Dermatol (1979) 1.39
Diagnostic accuracy and image quality using a digital camera for teledermatology. Telemed J (1999) 1.38
GM-CSF, carboplatin, doxorubicin: a phase I study. Cancer Chemother Pharmacol (1994) 1.38
Alcohol intake and early-onset basal cell carcinoma in a case-control study. Br J Dermatol (2014) 1.38
Neurodevelopment in children with single-suture craniosynostosis and plagiocephaly without synostosis. Plast Reconstr Surg (2001) 1.34
Neutrophil-mediated epithelial injury during transmigration: role of elastase. Am J Physiol Gastrointest Liver Physiol (2001) 1.33
In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet (1980) 1.30
Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol (1998) 1.29
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group. Br J Cancer (1998) 1.27
The czc operon of Alcaligenes eutrophus CH34: from resistance mechanism to the removal of heavy metals. J Ind Microbiol (1995) 1.27
The role of radiotherapy in the treatment of malignant sweat gland neoplasms. Cancer (1990) 1.26
Herpes gestationis: clinical and histologic features of twenty-eight cases. J Am Acad Dermatol (1983) 1.26
A nonsense mutation causes hereditary goitre in the Afrikander cattle and unmasks alternative splicing of thyroglobulin transcripts. Proc Natl Acad Sci U S A (1987) 1.26
Measurement of chemopreventive efficacy in skin biopsies. Anal Quant Cytol Histol (2001) 1.25
Loss of annexin II heavy and light chains in prostate cancer and its precursors. Cancer Res (2001) 1.25
Effect of oral isotretinoin on dysplastic nevi. J Am Acad Dermatol (1989) 1.25
Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft. Cancer Res (1997) 1.24
Regulation of neutrophil activation in acute lung injury. Chest (1999) 1.23
Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J Urol (1998) 1.23
Dose de-escalation chemoprevention trial of alpha-difluoromethylornithine in patients with colon polyps. J Natl Cancer Inst (1994) 1.23
High-dose dexamethasone for prevention of cis-platin-induced vomiting. Cancer Chemother Pharmacol (1981) 1.21
Karyometry in the early detection and chemoprevention of intraepithelial lesions. Eur J Cancer (2005) 1.20
Pharmacokinetics of very high-dose oral melphalan in cancer patients. Am J Clin Oncol (1990) 1.20
Cutaneous plasmacytomas in myeloma. Relationship to tumor cell burden. Arch Dermatol (1978) 1.19
The pharmacokinetics of daunomycin in man. Clin Pharmacol Ther (1971) 1.16
Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa. Am J Physiol (1999) 1.16
Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies. Cancer Genet Cytogenet (1996) 1.15
Dexamethasone as an antiemetic in patients treated with cisplatin. N Engl J Med (1981) 1.14
Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy. Clin Cancer Res (2000) 1.13
Lysosomes and the skin. J Invest Dermatol (1975) 1.13
The effect of phenobarbital on cyclophosphamide antitumor activity. Cancer Res (1976) 1.13
Nuclear morphometry in solar keratosis. Anal Quant Cytol Histol (1998) 1.12
Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas. Cancer Res (1999) 1.12
Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke. J Neurol Neurosurg Psychiatry (2005) 1.11
Cloning of TC-1 (C8orf4), a novel gene found to be overexpressed in thyroid cancer. Genomics (2000) 1.10
Hydrolysis and protein binding of melphalan. J Pharm Sci (1978) 1.10
Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett (1994) 1.10
Measurement of pH in the rat epididymis in vivo. J Reprod Fertil (1978) 1.09
Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine. Cancer Epidemiol Biomarkers Prev (2000) 1.09
Corrected nucleotide sequence of M13mp18 gene III. Gene (1992) 1.08
Mitoxantrone in epithelial carcinoma of the ovary. A Southwest Oncology Group study. Am J Clin Oncol (1984) 1.08
Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst (2009) 1.08
Community responses to the disabled and the dental profession's responsibility. J Can Dent Assoc (1985) 1.08
Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array. Prostate (2001) 1.08
Proteinases of human epidermis; a possible mechanism for polymorphonuclear leukocyte chemotaxis. Biochim Biophys Acta (1976) 1.08
Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults. Int J Cancer (2001) 1.07
A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev (2001) 1.06
Cutaneous granulomatosis in Crohn's disease. Arch Dermatol (1982) 1.06
Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. Prog Clin Biol Res (1980) 1.06
Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia. Cancer Chemother Pharmacol (1999) 1.05
Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa. J Natl Cancer Inst (1999) 1.05
Use of a food frequency questionnaire to screen for dietary eligibility in a randomized cancer prevention phase III trial. Cancer Epidemiol Biomarkers Prev (1997) 1.05
Deficiency of Src homology 2-containing phosphatase 1 results in abnormalities in murine neutrophil function: studies in motheaten mice. J Immunol (2000) 1.05
Evidence for physical and functional association between EMB-5 and LIN-12 in Caenorhabditis elegans. Science (1996) 1.04
Investigating sun-damaged skin and actinic keratosis with optical coherence tomography: a pilot study. Technol Cancer Res Treat (2003) 1.04
Subclavian MR arteriography: reduction of susceptibility artifact with short echo time and dilute gadopentetate dimeglumine. Radiology (2000) 1.04
Quality of nucleic acids extracted from fresh prostatic tissue obtained from TURP procedures. J Urol (2000) 1.03
Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells. Cancer Epidemiol Biomarkers Prev (1994) 1.03
Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction. Cancer Epidemiol Biomarkers Prev (1999) 1.02
[A clinical research for eosinophilic meningoencephalitis caused by angiostrongyliasis]. Zhonghua Nei Ke Za Zhi (1999) 1.02
Dynamic DNA hybridization on a chip using paramagnetic beads. Anal Chem (1999) 1.02
A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma. Cancer (1985) 1.02
Fructose and carbonyl metabolites as endogenous toxins. Chem Biol Interact (2008) 1.01
Skin carotenoid status measured by resonance Raman spectroscopy as a biomarker of fruit and vegetable intake in preschool children. Eur J Clin Nutr (2012) 1.01
Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study. Anticancer Drugs (2003) 1.01
Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol (2007) 1.01
A cross-cultural study of family and peer correlates of adolescent misconduct. Dev Psychol (1998) 1.01